Ohh-Med UK operations will be based in London and will run a call centre for customer sales and support of the erectile dysfunction device Vertica. Credit: New Africa/shutterstock

Israeli medtech startup Ohh-Med Medical is breaking into the UK market with the launch of Ohh-Med UK – a fully owned subsidiary.

The branch of operations will be based in London and will run a call centre for customer sales and support of Vertica, a medical device to treat long term erectile dysfunction (ED).

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The device to treat ED is the company’s lead product, a non-invasive at home treatment for ED that uses radiofrequency technology to rejuvenate the natural erectile mechanism by improving collagen quality in the penile erectile tissues.

Discussing the Ohh-Med expansion, Ohh-Med CEO Daniel Lischinsky said: “Our experience in Israel selling thousands of medical devices through our sophisticated call centre and online shop has convinced me that we can copy this success in the United Kingdom, which is a huge market for Vertica.”

The device has been on sale since 2022 and in December it received the European Medical Devices Regulation (CE-MDR) approval allowing them to market throughout the EU.

Lischinsky added: “The results of our first clinical study, showing more than 85% success rate, have recently been published in a leading scientific journal, the IJIR – International Journal of Impotence Research, a member of the Nature group of publications. Now we have the scientific proof to support what our customers have been saying.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Solutions for ED are becoming more popular and available to the public. In June 2023 Futura Medical’s over-the-counter (OTC) Eroxon gel for ED received US Food and Drug Administration (FDA) approval.